ATOS
Atossa Therapeutics·NASDAQ
--
--(--)
--
--(--)
ATOS Filings
Filing Date
Form Description
Form Type
2026-03-25
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-25 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-25
Form 8-K - Current report
Key Events
2026-03-25 · Key Events
Form 8-K - Current report
2026-03-20
Form PRE 14A - Other preliminary proxy statements
Key Events
2026-03-20 · Key Events
Form PRE 14A - Other preliminary proxy statements
2026-02-20
Form 8-K - Current report
Key Events
2026-02-20 · Key Events
Form 8-K - Current report
2026-02-20
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-20 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-20
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-20 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-17
Form 8-K - Current report
Key Events
2026-02-17 · Key Events
Form 8-K - Current report
2026-02-11
Form 8-K - Current report
Key Events
2026-02-11 · Key Events
Form 8-K - Current report
2026-01-30
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Ownership
2026-01-30 · Ownership
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
2026-01-26
Form 8-K - Current report
Key Events
2026-01-26 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
